Plasma‐based biomarkers of Alzheimer’s Disease in a multi‐ethnic population: A Cross‐Sectional analysis from the WHICAP Study
Aanya Bahl(Columbia University), Yian Gu(Columbia University Irving Medical Center), Jeffrey L. Dage(Indiana University School of Medicine), Danurys Sanchez(Columbia University Irving Medical Center), Lawrence S. Honig(Columbia University), Richard Mayeux(Columbia University), Min Suk Kang(NewYork–Presbyterian Hospital), Dolly Reyes‐Dumeyer(Columbia University), Rafael Lantigua, Jennifer J. Manly(Alzheimer’s Disease Neuroimaging Initiative), Adam M. Brickman(Columbia University)
Cited by 0
Related Papers
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|18.9k
Diagnosis and management of dementia with Lewy bodies
|Neurology|2017|4.4k
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k
Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study
|The Lancet Neurology|2013|3.1k
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
|New England Journal of Medicine|2014|2k